NCT07711418
- Conditions
- Moderate-to-severe Atopic Dermatitis
- Locations
-
- Nektar Investigative Site The Bronx, New York, United States
Clinical trial condition
Moderate-to-severe Atopic Dermatitis
Explore clinical trials studying Moderate-to-severe Atopic Dermatitis. Study availability and eligibility vary by location and protocol.
23 public trials
5 recruiting studies
Moderate-to-severe Atopic Dermatitis trial results
NCT07690371
- Conditions
- Moderate-to-severe Atopic Dermatitis
- Locations
-
- Nektar Investigative Site St. Petersburg, Florida, United States
NCT06934252
- Conditions
- Moderate-to-severe Atopic Dermatitis
- Locations
-
- Paratus Clinical Research - Canberra Trial Clinic Belconnen, Australian Capital Territory, Australia
- Paratus Clinical Brisbane Pty Ltd Albion, Brisbane, Australia
- Paratus Clinical Research Western Sydney Blacktown, New South Wales, Australia
- Paratus Clinical Research Central Coast Kanwal, New South Wales, Australia
NCT07211542
- Conditions
- Moderate-to-severe Atopic Dermatitis
- Locations
-
- Dermatology Hospital of Southern Medical University Guangzhou, Guangdong, China
NCT03057860
- Conditions
- Moderate-to-severe Atopic Dermatitis
- Locations
-
- Clinics for Dermatology, Allergy and Venerology, Hannover Medical School Hanover, Lower Saxony, Germany
- Department of Dermatology, UniversityAllergyCenter, Medical Faculty Carl Gustav Carus, TU Dresden Dresden, Saxony, Germany
- Head Centre for Inflammatory Skin Diseases, Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Campus Kiel Kiel, Schleswig-Holstein, Germany
Enrolling by Invitation
A Study to Evaluate JYP0061 Tablets in Patients With Moderate-to-severe Atopic Dermatitis
NCT06158490
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
- Locations
-
- Huashan Hospital, Fudan University Shanghai, Shanghai Municipality, China
Not Yet Recruiting
Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants Aged 6 to 23 Months With Moderate-to Severe Atopic Dermatitis
NCT07660835
- Conditions
- Moderate-to-severe Atopic Dermatitis
- Locations
-
Not specified
Not Yet Recruiting
A Study to Evaluate the Efficacy and Safety of AK139 in Patients With Moderate-to-severe Atopic Dermatitis
NCT07502222
- Conditions
- Moderate-to-severe Atopic Dermatitis
- Locations
-
Not specified
Not Yet Recruiting
A Phase II Study of QLS12010 Capsules in Adults With Moderate to Severe Atopic Dermatitis
NCT07344051
- Conditions
- Moderate-to-severe Atopic Dermatitis
- Locations
-
Not specified
NCT05899816
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
- Locations
-
- Affiliated Dermatology Scottsdale, Arizona, United States
- Center for Dermatology and Plastic Surgery Scottsdale, Arizona, United States
- Scottsdale Clinical Trials Scottsdale, Arizona, United States
- Medical Advancement Centers of Arizona Tempe, Arizona, United States